Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2009
02/10/2009US7488591 Controlling formation of acidic sugar chain associated with heterologously expressed glycoproteins in pichia; preparing less antigenic polypeptides; pharmacology; drug design; gene participating in addition of mannose phosphate to a sugar chain in a core-like sugar chain of a glycoprotein is controlled
02/10/2009US7488590 Fusion of Fc domains with biologically active peptides; selecting peptide that modulates the activity of AGP-3, preparing a gene construct; expressing the pharmacologically active compound in which an Fc domain is covalently linked to peptide
02/10/2009US7488587 Nucleic acid; use identifying the enzyme inhibitors which are used as antitumor agents; detection of cells expressing the enzyme
02/10/2009US7488586 PRO4409 polypeptides
02/10/2009US7488488 Polypeptide, polynucleotide, vector, transformant, antibody, vaccine, and receptor binding assay; miticide vaccines or prophylactic and preventitive vaccines for piroplasmosis, Q fever, or viral encephalitis
02/10/2009CA2329776C Antibody against lar phosphatase subunit
02/10/2009CA2284136C Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
02/10/2009CA2210951C Modified thermostable dna polymerase
02/10/2009CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce)
02/05/2009WO2009018537A2 Novel fungal enzymes
02/05/2009WO2009018424A2 Methods for determination of protein phosphatase activity, and uses in predicting therapeutic outcomes
02/05/2009WO2009017673A2 Methods, compositions, and kits for one-step dna cloning using dna topoisomerase
02/05/2009WO2009017441A1 Polypeptide having nadh dependent hmf reductase activity
02/05/2009WO2009017087A1 Immobilized lipase and method for producing the same
02/05/2009WO2009016839A1 Method for measurement of concentration of antigen
02/05/2009WO2009016275A2 Method for enzyme cleavage of polysaccharides derived from algae
02/05/2009WO2009016249A2 Transgenic plants with increased stress tolerance and yield
02/05/2009WO2009016208A2 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms
02/05/2009WO2009016166A1 Maize having improved digestibility
02/05/2009WO2009015951A1 Compositions comprising perhydrolases and alkylene glycol diacetates
02/05/2009WO2009015843A1 Novel immunotherapy against neuronal and brain tumors
02/05/2009WO2009015840A2 Polypeptide for targeting of neural cells
02/05/2009WO2009015505A1 Interactions between plant species separated by species barriers and uses thereof
02/05/2009WO2009015491A1 Umps isoforms as novel predictive markers and therapeutic targets for chemotherapeutics
02/05/2009WO2009007661A3 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma
02/05/2009WO2008153815A3 Variants of an alpha-amylase with improved production levels in fermentation processes
02/05/2009WO2008145865A3 Mutated hyperthermophilic phosphotriesterases and uses thereof
02/05/2009WO2008144791A3 Method for converting xylose or substrate solutions containing xylose
02/05/2009WO2008140500A8 Hyaluronidase inhibitors as anti-cancer agents
02/05/2009WO2008125623A3 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
02/05/2009WO2008125069A3 Method of increasing of the photosynthetic carbon dioxide assimilation yield
02/05/2009WO2008124048A3 Multizymes and their use in making polyunsaturated fatty acids
02/05/2009WO2008121813A3 Modulation of cytokine production
02/05/2009WO2008112459A3 Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
02/05/2009WO2008062317A4 Beta-mannanase from coffee berry borer, hypothenemus hampei, and uses thereof
02/05/2009US20090038023 Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
02/05/2009US20090036695 Oil Biosynthesis
02/05/2009US20090036648 EGVI Endoglucanase and Nucleic Acids Encoding the Same
02/05/2009US20090036537 Aromatic triamide-lanthanide complexes
02/05/2009US20090036419 Compounds useful as raf kinase inhibitors
02/05/2009US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis
02/05/2009US20090036366 Inhibitors of human plasmin derived from the kunitz domains
02/05/2009US20090036365 Inhibitors of human plasmin derived from the kunitz domains
02/05/2009US20090036320 Rational Design of Binding Proteins That Recognize Desired Specific Sequences
02/05/2009US20090036318 Class II Human Histone Deacteylases, and Uses Related Thereto
02/05/2009US20090035839 Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof
02/05/2009US20090035828 Method For the Preparation of Cross Linked Protein Crystals
02/05/2009US20090035827 O-acetyltransferase from Neisseria Meningitidis, Compositions and Methods
02/05/2009US20090035820 Nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; detergents; leather; food; dairyproducts; drugs; cheeses; tanning; cost efficiency; industrial scale
02/05/2009US20090035800 Novel Use of Fluorescence Resonance Energy Transfer
02/05/2009US20090035799 Novel trypsin family serine proteases
02/05/2009US20090035771 gene expression; probes, primers, antibodies
02/05/2009US20090035748 Bromelain as a clinical sample pre-treatment, lysis agent and nuclease inhibitor
02/05/2009US20090035415 Method of selecting barley variety, barley beta-amylase gene and process for producing malt alcoholic beverage
02/05/2009US20090035324 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections
02/05/2009US20090035293 Amylases for Pharmaceutical Use
02/05/2009US20090035291 Therapeutic use of adpase enhanced apyrases
02/05/2009US20090035217 Truncated Fragments of Alpha-Synuclein in Lewy Body Disease
02/05/2009US20090032466 Agent for Increasing Rejection with a Permeable Membrane, Process for Increasing the Rejection, Permeable Membrane and Process for Water Treatment
02/05/2009DE102007036756A1 Neue Proteasen und Wasch- und Reinigungsmittel, enthaltend diese neuen Proteasen New proteases and detergents and cleaning agents containing these novel proteases
02/05/2009CA2695384A1 Bi-dentate compounds as kinase inhibitors
02/05/2009CA2695112A1 Elongases and processes for the production of polyunsaturated fatty acids in transgenic organisms
02/05/2009CA2694944A1 Polypeptide having nadh dependent hmf reductase activity
02/05/2009CA2694899A1 Maize having improved digestibility
02/05/2009CA2694808A1 Novel immunotherapy against neuronal and brain tumors
02/05/2009CA2694329A1 Methods for determination of protein phosphatase activity, and uses in predicting therapeutic outcomes
02/05/2009CA2694142A1 Transgenic plants with increased stress tolerance and yield
02/04/2009EP2020441A1 Tetrasphaera lipase
02/04/2009EP2020439A1 Eukaryotic amadoriase having excellent thermal stability, gene and recombinant dna for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability
02/04/2009EP2020438A1 Treatment of pompe's disease
02/04/2009EP2020437A1 (Nife)-hydrogenases having an improved resistance to dioxygen, process for obtaining them and their applications
02/04/2009EP2019867A1 Method for multiparallel construction of host/vector-systems for expression of proteins
02/04/2009EP2019865A1 Stable vaccine formulation
02/04/2009EP2019864A2 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity
02/04/2009EP1232269B1 Method for purifying recombinant hexose oxidase
02/04/2009EP1127944B1 Methods for screening compounds inhibiting inflammatory cytokine production
02/04/2009CN101360831A Recombinant N-glycosylated proteins from procaryotic cells
02/04/2009CN101360822A Integration of sample storage and sample management for life science
02/04/2009CN101358184A Hemocoagulase agkistrodon
02/04/2009CN101358183A Red bean carbonyl reductase, preparation method and use thereof
02/04/2009CN100457909C Methods for large scale protein production in prokaryotes
02/04/2009CN100457908C Recombinant stratum corneum chymotryptic enzyme (SCCE)
02/04/2009CN100457897C Preparation process of and use of thrombus dissolving enzyme
02/04/2009CN100457894C Fermentation process of proudcing L-glutamine and bacteria of producing L-glutamine
02/04/2009CN100457776C Hepatitis c virus NS5B polymerase inhibitor binding pocket
02/04/2009CN100456935C Method and composition for the prevention or inhibition of hardening and its effect during the baking process of baked products
02/03/2009US7485777 Introducing nucleotide sequence into a plant cell encoding a variant of algae protoporphyrinogen IX oxidase that lacks the FAD binding sequence; nucleotide sequence is expressed and plant cell is regenerated into transgenic plant; transformation
02/03/2009US7485776 Disease resistance factors
02/03/2009US7485775 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
02/03/2009US7485771 Transforming plants with nucleotide sequences coding chorella oxidoreductase and increasing their tolerance of ammonia toxicity and osmotic stress
02/03/2009US7485769 Transgenic mammals
02/03/2009US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases
02/03/2009US7485706 Has a domain that preferentially binds to aggregations comprising at least two monomeric proteins linked to a second domain that recruits the aggregation modifying protein; neurotoxicity; neurodegenerative diseases
02/03/2009US7485700 Interferon-like protein ZCYTO21
02/03/2009US7485618 FGF-5 supported and binding peptides
02/03/2009US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression
02/03/2009US7485450 Trangenic escherichia comprising deactivated threonine degradation-associated operon (tdcBC) and phosphoenol pyruvate carboxykinase for enhancing threonine biosynthesis for use in cosmetic, feeds and medicines
02/03/2009US7485447 Secreted polypeptide having protease activity on soybean meal protein and comprising at least three non-polar or uncharged polar amino acids within the last four amino acids of the C-terminus; polynucleotides, expression vectors, host cells, transgenic plants; stability; genetic engineering
02/03/2009US7485446 Mutant murine leukemia virus proteus with amino acid substitution; infection efficiency; generating mutant library
02/03/2009US7485445 Nucleic acid encoding plant lipase polypeptide; host cell from Pichia containing expression vector; genetic engineering; waste water cleaning; sunscreen agents